• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚全身性抗生素的门诊使用情况。

Outpatient use of systemic antibiotics in croatia.

作者信息

Stimac D, Vukusić I, Culig J

机构信息

Zagreb Institute of Public Health, Mirogojska cesta 16, 10000, Zagreb, Croatia.

出版信息

Pharm World Sci. 2005 Jun;27(3):230-5. doi: 10.1007/s11096-004-3704-z.

DOI:10.1007/s11096-004-3704-z
PMID:16096893
Abstract

OBJECTIVE

The aim was to estimate the outpatient utilization of antibacterials for systemic use in Zagreb, Croatia, and to define the antibiotic utilization characteristics and consequences.

METHOD

Using the WHO ATC/DDD methodology, the number of defined daily doses per 1000 inhabitants per day (DDDs/TID) was calculated for each individual antibiotic and ATC system levels were calculated from data collected on the number and size of packages prescribed and dispensed from pharmacies. The Drug Utilization 90% (DU90%) method was used to evaluate the quality of drug prescribing.

RESULTS

The total utilization of antibiotics was found to be extremely high, 55.0 DDDs/TID. The leading antibiotic was amoxicillin + clavulanic acid with 14.7 DDDs/TID. Penicillins accounted for the highest utilization (46.3%) expressed in DDDs/TID (25.4), followed by cephalosporins and macrolides 25 and 12.5% of utilization, respectively expressed in DDDs/TID), tetracyclines, quinolones, aminoglycosides and other agents. Nine of 27 antibiotics fell within the DU90% segment. The cost/DDD foldrugs within DU90% segment was 1.2 EUR, for drugs beyond DU90% segment was 1.4 EUR, and the average was 1.2 EUR.

CONCLUSION

Irrational prescribing and preference to more expensive drugs have been reported in Zagreb. Therefore, the risk of resistance of microorganisms to beta-lactamase antibiotics, macrolides and quinolones could be expected. Prescribing patterns should be changed by introducing national guidelines on rational antibiotic prescribing, monitoring and evaluation of their implementation. Additional continuing education of physicians and pharmacists from independent sources should be organized and proper education should be provided to patients.

摘要

目的

旨在评估克罗地亚萨格勒布全身用抗菌药物的门诊使用情况,并确定抗生素使用特征及后果。

方法

采用世界卫生组织解剖学治疗学及化学分类系统/限定日剂量(WHO ATC/DDD)方法,计算每种抗生素的每日每千居民限定日剂量数(DDDs/TID),并根据药房处方和调配的药品包装数量及规格数据计算 ATC 系统级别。采用药物利用 90%(DU90%)方法评估药物处方质量。

结果

发现抗生素总使用量极高,为 55.0 DDDs/TID。主要抗生素为阿莫西林+克拉维酸,用量为 14.7 DDDs/TID。以 DDDs/TID 表示,青霉素类的使用量最高(46.3%,即 25.4 DDDs/TID),其次是头孢菌素类和大环内酯类,分别占使用量的 25%和 12.5%(以 DDDs/TID 表示),还有四环素类、喹诺酮类、氨基糖苷类及其他药物。27 种抗生素中有 9 种落在 DU90%区间内。DU90%区间内药物的成本/DDD 为 1.2 欧元,超出 DU90%区间的药物为 1.4 欧元,平均为 1.2 欧元。

结论

据报道,萨格勒布存在不合理用药及偏好使用更昂贵药物的情况。因此,可以预期微生物对β-内酰胺酶抗生素、大环内酯类和喹诺酮类产生耐药性的风险。应通过引入合理抗生素处方的国家指南、监测和评估其实施情况来改变处方模式。应组织来自独立来源的医生和药剂师进行额外的继续教育,并向患者提供适当的教育。

相似文献

1
Outpatient use of systemic antibiotics in croatia.克罗地亚全身性抗生素的门诊使用情况。
Pharm World Sci. 2005 Jun;27(3):230-5. doi: 10.1007/s11096-004-3704-z.
2
Outpatient consumption of antibiotics in the City of Zagreb (2006-2010).萨格勒布市门诊抗生素消费情况(2006 - 2010年)
Med Glas (Zenica). 2014 Feb;11(1):216-20.
3
Utilization of cardiovascular drugs in Zagreb 2001-2005.2001 - 2005年萨格勒布心血管药物的使用情况
Acta Cardiol. 2010 Apr;65(2):193-201. doi: 10.2143/AC.65.2.2047053.
4
[Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].[梅迪穆尔耶地区抗生素耐药性与抗生素消费监测]
Acta Med Croatica. 2004;58(4):285-91.
5
The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.塞尔维亚南巴奇卡地区非甾体抗炎药的门诊使用情况。
Int J Clin Pharm. 2011 Apr;33(2):246-51. doi: 10.1007/s11096-011-9487-0. Epub 2011 Feb 25.
6
Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).克罗地亚(里耶卡)和瑞典(斯德哥尔摩)非甾体抗炎药处方质量。
Eur J Clin Pharmacol. 2002 Jun;58(3):209-14. doi: 10.1007/s00228-002-0449-2. Epub 2002 Apr 26.
7
Outpatient use of systemic antibiotics in Poland: 2004-2008.2004 - 2008年波兰全身性抗生素的门诊使用情况
Przegl Epidemiol. 2014;68(3):435-41, 543-7.
8
Trends in the Outpatient Utilization of Antipsychotic Drugs in the City of Zagreb in the Ten-Year Period as a Tool to Assess Drug Prescribing Rationality.以十年期萨格勒布市抗精神病药物门诊使用趋势作为评估药物处方合理性的工具
Psychiatr Danub. 2016 Dec;28(4):415-419.
9
Antibiotic prescribing in general practice: striking differences between Italy (Ravenna) and Denmark (Funen).全科医疗中的抗生素处方:意大利(拉文纳)和丹麦(菲英岛)之间的显著差异。
J Antimicrob Chemother. 2002 Dec;50(6):989-97. doi: 10.1093/jac/dkf239.
10
A study on the quality of outpatient prescription of psychopharmaceuticals in the City of Zagreb 2006-2009.2006 - 2009年萨格勒布市精神药物门诊处方质量研究
Coll Antropol. 2014 Jun;38(2):717-24.

引用本文的文献

1
Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?塞尔维亚南巴卡地区与一些斯堪的纳维亚国家在门诊抗生素使用方面是否存在显著差异?
Front Public Health. 2018 Mar 29;6:91. doi: 10.3389/fpubh.2018.00091. eCollection 2018.
2
Outpatient use of systemic antibiotics in Croatia.
Pharm World Sci. 2006 Feb;28(1):39-40; author reply 41. doi: 10.1007/s11096-006-9000-3. Epub 2006 Apr 28.

本文引用的文献

1
Problems in collecting comparable national drug use data in Europe: the example of antibacterials.欧洲收集可比国家药物使用数据的问题:以抗菌药物为例。
Eur J Clin Pharmacol. 2003 Apr;58(12):843-9. doi: 10.1007/s00228-003-0572-8. Epub 2003 Mar 18.
2
Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).克罗地亚(里耶卡)和瑞典(斯德哥尔摩)非甾体抗炎药处方质量。
Eur J Clin Pharmacol. 2002 Jun;58(3):209-14. doi: 10.1007/s00228-002-0449-2. Epub 2002 Apr 26.
3
A European study on the relationship between antimicrobial use and antimicrobial resistance.
一项关于抗菌药物使用与抗菌药物耐药性之间关系的欧洲研究。
Emerg Infect Dis. 2002 Mar;8(3):278-82. doi: 10.3201/eid0803.010192.
4
Variation in antibiotic use in the European Union.欧盟抗生素使用情况的差异。
Lancet. 2001 Jun 9;357(9271):1851-3. doi: 10.1016/S0140-6736(00)04972-2.
5
Non-hospital consumption of antibiotics in Spain: 1987-1997.
J Antimicrob Chemother. 2000 Mar;45(3):395-400. doi: 10.1093/jac/45.3.395.
6
Quality assessment of drug sales data: the case of antibacterials in Iceland.
Pharm World Sci. 1999 Oct;21(5):221-6. doi: 10.1023/a:1008765419567.
7
The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.人类群体中抗菌药物消费量与耐药频率之间的关系。
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1152-6. doi: 10.1073/pnas.96.3.1152.
8
Drug utilization 90%--a simple method for assessing the quality of drug prescribing.药物利用度90%——一种评估药物处方质量的简单方法。
Eur J Clin Pharmacol. 1998 Apr;54(2):113-8. doi: 10.1007/s002280050431.
9
Application of the ATC/DDD methodology to monitor antibiotic drug use.应用解剖治疗学分类系统/限定日剂量方法监测抗生素使用情况。
Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):20-4. doi: 10.1007/BF01584358.
10
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.芬兰大环内酯类抗生素消费变化对A组链球菌红霉素耐药性的影响。芬兰抗菌药物耐药性研究小组。
N Engl J Med. 1997 Aug 14;337(7):441-6. doi: 10.1056/NEJM199708143370701.